Kelley Yuan

ORCID: 0000-0002-8238-5578
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Oncology and Treatments
  • Retinal Diseases and Treatments
  • Retinal Development and Disorders
  • Cancer-related Molecular Pathways
  • Acute Lymphoblastic Leukemia research
  • Toxoplasma gondii Research Studies
  • Phagocytosis and Immune Regulation
  • interferon and immune responses
  • CNS Lymphoma Diagnosis and Treatment
  • Retinopathy of Prematurity Studies
  • Advanced Breast Cancer Therapies
  • Vitamin D Research Studies
  • Glioma Diagnosis and Treatment
  • Ubiquitin and proteasome pathways
  • Retinoids in leukemia and cellular processes
  • Corneal Surgery and Treatments
  • History of Medicine Studies
  • Childhood Cancer Survivors' Quality of Life
  • Retinal and Optic Conditions
  • Angiogenesis and VEGF in Cancer
  • Empathy and Medical Education
  • Nuclear Receptors and Signaling
  • Cancer Immunotherapy and Biomarkers
  • Retinal and Macular Surgery
  • Parkinson's Disease and Spinal Disorders

Sidney Kimmel Cancer Center
2019-2022

Thomas Jefferson University
2020

ORCID
2019

University of Tennessee Health Science Center
2017-2019

Cincinnati Eye Institute
2017

Pennsylvania State University
2017

Purpose: Vitreous seeding remains the primary reason for treatment failure in eyes with retinoblastoma (Rb). Systemic and intra-arterial chemotherapy, each its own inherent set of complications, have improved salvage rates advanced disease, but location biology vitreous seeds present a fundamental challenge developing treatments minimal toxicity risk. The aim this study was to target platelet-derived growth factor (PDGF)– PDGF-receptor β (PDGFRβ) signaling pathway investigate role Rb seeds,...

10.1167/iovs.18-24359 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2018-09-05

Growing evidence attests to the vital role vitamin D plays in dynamics of immune system.Active 1,25(OH)2D3 binds receptor (VDR) form a ligand-activated complex able control transcription nucleus.We examined various mechanisms through which D3 alters and enhances responses variety skin conditions, as well pathways it activates inhibit progression tumors carcinomas.The hormone primarily elicits change either an inflammation modulator or cancer suppressor.Also addressed are current advancements...

10.7150/oncm.19262 article EN Oncomedicine 2017-01-01

Methotrexate (MTX) a folate antagonist is often given in high doses (≥500 mg/m2) to treat variety of disease processes. While inpatient administration has been the norm, outpatient administration, shown be safe, effective, and patient centered. Here we describe development an HDMTX protocol our initial experience.All patients were receive their first cycle hospital ensure they tolerate it well also use this time assist training for home administration. The involved continuous IV sodium...

10.3389/fonc.2021.773397 article EN cc-by Frontiers in Oncology 2022-01-20

PurposeThe liver is the most common site of uveal melanoma (UM) metastasis with approximately 50% UM patients being affected.With no proven therapies that mitigate metastases mortality rate 85% within first year after detection disease.In this study, we provide a mechanistic understanding de-regulation TP53-MDM2 pathway in UM, which plays central role tumor biology. MethodsWe investigated signaling microenvironment taken from both murine orthotopic xenograft and post-mortem metastatic human...

10.17140/ooj-3-119 article EN The Ophthalmology - Open Journal 2019-12-30

In the face of lost battles, long hours, and daunting challenges in medicine, it is easy to overlook happy endings leaps progress. many cases, doctor patient are both blips each other’s lives—the merely another name on rounding list; hospital nothing more than an interruption patient’s daily routine. At hospital, two worlds brush paths then cleanly separate after treatment. As a first-year medical student accustomed poring over textbooks diagrams, I often forgot about impact could one day...

10.1097/acm.0000000000001973 article EN Academic Medicine 2017-11-29
Coming Soon ...